Logo image of IFX.CA

IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

TSX-V:IFX - TSX Venture Exchange - CA4524352099 - Common Stock - Currency: CAD

1.32  +0.03 (+2.33%)

Fundamental Rating

5

Taking everything into account, IFX scores 5 out of 10 in our fundamental rating. IFX was compared to 9 industry peers in the Containers & Packaging industry. IFX has an excellent financial health rating, but there are some minor concerns on its profitability. IFX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IFX was profitable.
In the past year IFX had a positive cash flow from operations.
In the past 5 years IFX has always been profitable.
Each year in the past 5 years IFX had a positive operating cash flow.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

IFX has a Return On Assets (6.38%) which is comparable to the rest of the industry.
IFX has a worse Return On Equity (9.05%) than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.12%, IFX is in line with its industry, outperforming 55.56% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IFX is in line with the industry average of 8.67%.
The 3 year average ROIC (7.65%) for IFX is below the current ROIC(8.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.38%
ROE 9.05%
ROIC 8.12%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of IFX (5.28%) is worse than 66.67% of its industry peers.
In the last couple of years the Profit Margin of IFX has grown nicely.
With a Operating Margin value of 7.36%, IFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of IFX has grown nicely.
IFX's Gross Margin of 16.75% is on the low side compared to the rest of the industry. IFX is outperformed by 77.78% of its industry peers.
IFX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.36%
PM (TTM) 5.28%
GM 16.75%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IFX is creating some value.
IFX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for IFX has been increased compared to 5 years ago.
Compared to 1 year ago, IFX has an improved debt to assets ratio.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

IFX has an Altman-Z score of 4.07. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
IFX has a Altman-Z score of 4.07. This is in the better half of the industry: IFX outperforms 77.78% of its industry peers.
The Debt to FCF ratio of IFX is 0.64, which is an excellent value as it means it would take IFX, only 0.64 years of fcf income to pay off all of its debts.
IFX has a better Debt to FCF ratio (0.64) than 88.89% of its industry peers.
IFX has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
IFX's Debt to Equity ratio of 0.11 is fine compared to the rest of the industry. IFX outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.64
Altman-Z 4.07
ROIC/WACC1.08
WACC7.49%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.44 indicates that IFX has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.44, IFX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
A Quick Ratio of 1.65 indicates that IFX should not have too much problems paying its short term obligations.
The Quick ratio of IFX (1.65) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.65
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

IFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 311.68%, which is quite impressive.
The Earnings Per Share has been growing by 36.43% on average over the past years. This is a very strong growth
Looking at the last year, IFX shows a quite strong growth in Revenue. The Revenue has grown by 13.92% in the last year.
Measured over the past years, IFX shows a small growth in Revenue. The Revenue has been growing by 6.26% on average per year.
EPS 1Y (TTM)311.68%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-85.63%
Revenue 1Y (TTM)13.92%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%5.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y66.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.99%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

IFX is valuated correctly with a Price/Earnings ratio of 12.00.
Based on the Price/Earnings ratio, IFX is valued a bit cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.32. IFX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 25.63 indicates a quite expensive valuation of IFX.
Based on the Price/Forward Earnings ratio, IFX is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of IFX to the average of the S&P500 Index (22.19), we can say IFX is valued inline with the index average.
Industry RankSector Rank
PE 12
Fwd PE 25.63
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IFX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX indicates a rather cheap valuation: IFX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.63
EV/EBITDA 5.15
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.18
PEG (5Y)0.33
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IFX!.
Industry RankSector Rank
Dividend Yield N/A

IMAFLEX INC

TSX-V:IFX (6/17/2025, 7:00:00 PM)

1.32

+0.03 (+2.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)05-27 2025-05-27
Earnings (Next)08-26 2025-08-26
Inst Owners10.17%
Inst Owner ChangeN/A
Ins Owners46.37%
Ins Owner ChangeN/A
Market Cap68.76M
Analysts84.44
Price Target2.04 (54.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)100%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.61%
Valuation
Industry RankSector Rank
PE 12
Fwd PE 25.63
P/S 0.62
P/FCF 4.63
P/OCF 3.85
P/B 1.06
P/tB 1.1
EV/EBITDA 5.15
EPS(TTM)0.11
EY8.33%
EPS(NY)0.05
Fwd EY3.9%
FCF(TTM)0.28
FCFY21.58%
OCF(TTM)0.34
OCFY25.98%
SpS2.14
BVpS1.25
TBVpS1.2
PEG (NY)0.18
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 9.05%
ROCE 10.89%
ROIC 8.12%
ROICexc 9.07%
ROICexgc 9.39%
OM 7.36%
PM (TTM) 5.28%
GM 16.75%
FCFM 13.32%
ROA(3y)7.21%
ROA(5y)9.25%
ROE(3y)9.67%
ROE(5y)13.04%
ROIC(3y)7.65%
ROIC(5y)10.7%
ROICexc(3y)8.55%
ROICexc(5y)12.05%
ROICexgc(3y)8.89%
ROICexgc(5y)12.53%
ROCE(3y)10.53%
ROCE(5y)14.7%
ROICexcg growth 3Y-20.84%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y5.71%
OM growth 3Y-10.09%
OM growth 5Y7.97%
PM growth 3Y-4.44%
PM growth 5Y29.09%
GM growth 3Y0.33%
GM growth 5Y3.9%
F-Score8
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 0.64
Debt/EBITDA 0.54
Cap/Depr 55.28%
Cap/Sales 2.71%
Interest Coverage 11.69
Cash Conversion 130.75%
Profit Quality 252.52%
Current Ratio 2.44
Quick Ratio 1.65
Altman-Z 4.07
F-Score8
WACC7.49%
ROIC/WACC1.08
Cap/Depr(3y)236.8%
Cap/Depr(5y)164.27%
Cap/Sales(3y)10.14%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)311.68%
EPS 3Y-4.09%
EPS 5Y36.43%
EPS Q2Q%-85.63%
EPS Next Y66.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.92%
Revenue growth 3Y0.73%
Revenue growth 5Y6.26%
Sales Q2Q%5.54%
Revenue Next Year23.99%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.96%
EBIT growth 3Y-9.43%
EBIT growth 5Y14.73%
EBIT Next Year119.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y918.3%
FCF growth 3Y29.22%
FCF growth 5Y23.11%
OCF growth 1Y2.46%
OCF growth 3Y25.19%
OCF growth 5Y10.31%